We are supporting hospitals and payers that require a continuous remote monitoring system to manage their high-risk patients and clinicians.
We are supporting biopharma companies that require a launch-ready platform solution to support COVID-19 clinical trials as well as those that need to transition to virtual data collection.
Updates
-
Collaborating to Bring 24/7 Mobile Tech to COVID-19
PhysIQ, UI Health and CMS team up on a project to use wearable remote monitoring and AI to predict risk of COVID-19.
-
How Artificial Intelligence, Biosensors May Have Saved Woman's Life in Fight Against Coronavirus
September 16, 2020NBC 5’s Lauren Petty tells the story of a woman who says the sensors saved her life.
-
National Institutes of Health Commissions PhysIQ to Develop COVID-19 Digital Biomarker
September 16, 2020The NIH has awarded physIQ a contract to develop an AI-based COVID-19 Decompensation Index to address the COVID-19 pandemic.
-
How physIQ’s AI technology became the perfect pandemic response tool
August 14, 2020Throughout the COVID-19 pandemic, businesses across healthcare have faced the challenge of retooling and pivoting their solutions to focus on the fight against COVID-19. But for MATTER startup physIQ, no pivoting, revising or overhauling was necessary.